ORGONE BLANKET AS A COMPLEMENTARY SUPPORT IN THE TREATMENT OF AN ATROPHIC-CANCER BIOPATHY.

A CASE REPORT

Tommaso Aprile, Fiorenzo Carlino, Salvatore Del Prete, Isabella Angelone, Antimo Cammisa, Fulvio Cusani, Nicola Dello Iacovo

Summary

Results of the treatment of a pancreatic adenocarcinoma with the support of an orgone blanket of the type devised by Wilhelm Reich are reported and discussed. At eight months from the diagnosis of the disease, the total-body PET CT scan no longer detected any pathological localization.

Introduction

In his book The Cancer Biopathy Reich reported several cases concerning the use of the orgone therapy for the treatment of biopathies (1) in humans, and specifically in atrophic and cancerous ones. In the text it is detailed that large masses of tumor cells dissolved, sometimes so fast that it became a problem, at times lethal, to dispose of the dead tumor cells and T-bacilli (2) through the kidneys, the liver, and the lymphatic system. As a research group,The Campania Felix, we decided to apply Reich’s experiences in consenting patients. We started around two years ago by treating an atrophic-cancerous biopathy, and other biopathies, with an orgone blanket. Being that orgone therapy is not officially recognized in Italy, we used it as a complementary support tool of the official medical therapies prescribed by the National Health Service (SSN).

In this article we report a case that, due to the unusual nature of the results, resembles some of those reported by Reich himself. The diagnoses, clinical examinations, prognoses and therapies were those prescribed and carried out by SSN’s personnel, and were done independently from the activity of our group.

Clinical case

A 67-year old male patient (B. C.) was suffering from diabetes mellitus (treated with Metformin and Lantus), hypercholesterolemia, arterial hypertension, and right bundle branch block. In anamnesis he underwent a proctological intervention for perianal fistula. In February 2017 he reported the appearance of abdominal pain, for which the following exams were performed:

EGDS (esophagus-gastro-duodenumoscopy): an extrinsic compression of the gastric wall. Echo of the abdomen: lesion of the uncinate pancreatic process of 3-3.5 cm. Oncological markers: within the limit. Chest-abdomen CT (March 10, 2017) (see Illustration 1): lesion of 46 x 31 mm to the uncinate process of the pancreas, unclear cleavage plan with the upper mesenteric artery, free venous vessels. Multiple loco-regional and retroperitoneal lymphadenopathies, the longest was of 18 mm in the retro-pancreatic site. No hepatic lesions. Centimetric adenoma at the right adrenal gland.

The patient then went to the Pancreas Institute of the Integrated University of Verona, Italy, on March 21, 2017, in good general conditions. He reported hyporexia from January and steatorrhea in close relationship with meals from a week. The clinical examination revealed a neoformation in the uncinate process of 41×31 mm infiltrating the arterial vessels; and presence of regional adenopathy. Percutaneous biopsy of the lesion was performed on March 30, 2017, with histological diagnosis of agobioptic frustule of adenocarcinoma (see Illustration 2).

On April 09, 2017 he was admitted at the Oncology Division of the Casa Sollievo della Sofferenza of San Giovanni Rotondo, Italy, where on April 11, 2017, he underwent a CT scan with contrast that confirmed the presence of a voluminous expansive formation of the pancreatic uncinate process, max 48 mm. It was indissociable from the horizontal portion of the duodenum which seemed to be at least partly incorporated. The lesion also infiltrated the upper mesenteric artery and licked the upper mesenteric vein. A tenuous thickening of the perilesional mesenteric adipose planes was associated with small scattered lympho-nodal nodules. More voluminous lymphadenopathies were located in celiac sites, up to about 15 mm, and in the hepatoduodenal ligament up to about 20 mm. The remaining pancreatic parenchyma appeared slightly dis-homogeneous with mild ectasia of the Wirsung duct. In the hepatic parenchyma, in the single arterial phase of the study, there were multiple and minuscule hyperdense focal points, with a maximum size of 7-8 mm, of suspected repetitive nature. Substantially unchanged a 20 mm hypodense nodulation in the context of the left adrenal gland.

The neoformation was judged to be inoperable, and a life expectancy of about 30 days was reported to the patient’s family. At this point the patient started using the orgone blanket, which we assembled (see Illustrations 3 and 4), one hour a day the first week, two hours a day the second week, and then for four hours a day.

Chemotherapy with Abraxane and Gemcitabine was administered to the patient as follows.

April 12, 2017: 1/1 cycle

April 21, 2017: 2/1 cycle

April 28, 2017: 3/1 cycle

May 19, 2017: 1/2 cycle

May 20, 2017: 2/2 cycle

June 05, 2017: 3/2 cycle – postponed due to diarrhoea

June 20, 2017: 1/3 cycle

June 28, 2017: 2/3 cycle

On July 11, 2017 the patient had CT performed with contrast. Compared to the previous exam the following was observed in the medical report: "Modest volumetric reduction of the known heteroformed expansive lesion of the pancreatic uncinate process, currently with a maximum diameter of 44 mm and with a more hypodense structure as per contextual necrotic-regressive phenomena. Reduced ectasia of the Wirsung duct upstream of the lesion and intrahepatic bile ducts. Reduced sizes of the lymphadenopathies: in the celiac site where they currently do not exceed the centimetre, and in the hepato-duodenal ligament where currently the largest one measures 1.5 cm. The small focal lengths with enhancement in the arterial phase appear almost completely disappeared from the liver. Left adrenal nodulation unchanged".

Chemotherapy was continued as follows. It should be outlined that the use of the orgone blanket (four hours per day) in this and in the following phase was never discontinued.

July 18, 2017: cycle 1/4

July 27, 2017: cycle 2/4

August 03, 2017: cycle 3/4

August 17, 2017: cycle 1/5

August 25, 2017: cycle 2/5

September 05, 2017: cycle 3/5

The CT scan with contrast was repeated on September 13, 2017 with the following results as reported in the medical notes: "It is observed a further volumetric reduction of the known heteroformed expansive lesion of the pancreatic uncinate process to 38 mm with lower enhancement of vascular structures. The ectasia of the Wirsung upstream is also reduced, while the calibre of the intrahepatic bile ducts and of the hepatocoledoco, currently of modest size, appear to be superimposable. The size of lymphadenopathies in the celiac area is unchanged and currently do not exceed one centimetre. In the liver, no obvious pathological focal lesions. Mild adrenal hypodense nodulation reduced to 17.5 mm. In the pulmonary area, only the presence of a shaded area of ground glass hyper-density of about 10 mm at the upper left lobe was present. Micro-nodulations hypodense against the left lobe of the thyroid".

Chemotherapy was continued as follows.

September 21, 2017: cycle 1/6

September 28, 2017: cycle 2/6

October 05, 2017: cycle 3/6

On October 24, 2017 PET Total Body CT scan was performed with the following results noted (see Illustrations 5 and 6): "ANOMALIES OF THE TRACER DISTRIBUTION ARE NOT OBSERVED. CONCLUSIONS: PRESENCE OF AREAS OF HYPERACCUMULATION OF THE RADIOPHARMACEUTICAL REFERRABLE TO A RECURRENT ILLNESS AND/OR RECURRING LESIONS IS NOT OBSERVED".

Observations and Conclusions

From the above results it can be observed a very clear improvement in the history of pancreatic cancer that is presently recognized by the scientific literature as one of the most aggressive and dramatic cancer pathologies.

The improvement was clearly evident with the disappearance of both the liver focal points and the pancreatic mass. We did not find in the literature similar results with the use of chemotherapy only, and it is possible that the complementary support of the orgone blanket has been decisive for this resounding healing process.

This can be explained by the observation that the orgone blanket produces, similarly to the accumulator, a concentration of orgone (vital) energy. This is then absorbed by the organism when it comes into contact with it, thus providing a generalized vagotonic effect and an increase of the body temperature. Microscopic observations show a "biological recharge" action on the red blood cells that appear progressively healthier, or more swollen, and characterized by well-defined contours and a characteristic bluish luminescence. In this way, the energetically-charged red blood cells are able to destroy the tumoral cells and the T-bacilli, whose presence was first discovered by Reich. These entities are always present in this type of pathology it appears.

The cancer tumour is only one of the symptom consequences of the decrease of the energetic level of the whole organism (known to Reich as a biopathy). The orgone therapy improves the general energetic state, and can lead to the remission of a large variety of pathologies. It is important to remind readers in this context that a simple Reich test on living blood allows a very early diagnosis of the cancer pathology, thus enabling determining situations of being "at risk" possibly years before the actual tumoral cells can develop. As a research group we are presently planning to perform the Reich blood test on our patients and that will be the subject of our next paper.

References:

A biopathy is a global disturbance of the energy system of an organism which results in illness. T-Bacilli are a claimed disease causing microscopic vesicle only the size of a few viral particles which Reich found occurred in blood when living tissue breaks down. It has been claimed to be seen with very strong light microscopy (see Reich W, The Cancer Biopathy).

Bibliography

Reich W, The Cancer Biopathy, Orgone Institute Press, New York, 1948 Maglione R, Methods and Procedures in Biophysical Orgonometry, GEDI Gruppo Editoriale, Rome, Italy, 2012 Grupo Espanol de Consenso en Cancer de Pancreas, Recommendations for Diagnosis, Staging and Treatment of Pancreatic Cancer (part I), Med Clin (Barc), 15;134(14):643-55, May 2010 Li D, et al, Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients with Metastatic Pancreas Adenocarcinoma, Clinical Colorectal Cancer, Volume 14, Issue 4, December 2015 De Meo J, The Orgone Accumulator Handbook, Natural Energy Works, Ashland, Usa, 1989 Kavouras J, Heilen Mit Orgonenergie, Turm Verlag, 2005 www.renatopalmieri.com (accessed August 2018) www.cellulacancerosa.it (accessed August 2018) www.heliognosis.com (accessed August 2018)

The Campania Felix is an independent research group based in Italy and is consisting of the following components:

Tommaso Aprile, oncologist

Salvatore Del Prete, orthopaedic surgeon

Fiorenzo Carlino, physiatrist and acupuncturist

Isabella Angelone, physiotherapist

Antimo Cammisa, physiotherapist

Fulvio Cusani, physiotherapist

Nicola Dello Iacovo, physiotherapist.

For contacts: fulvio.cusani@gmail.com

Figure 1 – Chest-abdomen CT scan carried out on March 10, 2017

Figure 2 – Hystological examination carried out on March 30, 2017

Figure 3 – Orgone blanket. Size 80 x 140 cm, weight 3 kg. The blanket is made by 2 external layers of wool; 2 internal layers of steel wool, separated by a layer of polyester. In use it is placed with the metal layer innermost to the patient.

Figure 4 – Section of the orgone blanket with composing materials

Figure 5 – PET total body CT scan carried out on October 24, 2017 – Medical report

Figure 6 – PET total body CT scan carried out on October 24, 2017 – Images